/
/
/

Eris Lifesciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016
₹873 Cr₹757 Cr₹807 Cr₹792 Cr₹773 Cr₹705 Cr₹727 Cr₹741 Cr₹720 Cr₹551 Cr₹486 Cr₹505 Cr₹467 Cr₹403 Cr₹423 Cr₹461 Cr₹399 Cr₹306 Cr₹332 Cr₹360 Cr₹349 Cr₹278 Cr₹310 Cr₹330 Cr₹293 Cr₹249 Cr₹266 Cr₹285 Cr₹274 Cr₹215 Cr₹252 Cr₹264 Cr₹251 Cr₹212 Cr₹209 Cr₹249 Cr₹185 Cr₹184 Cr₹184 Cr₹199 Cr₹182 Cr
₹2 Cr₹2 Cr₹2 L₹3 Cr₹3 Cr₹8 Cr₹4 Cr₹5 Cr₹2 Cr₹15 Cr₹4 Cr₹3 Cr₹99 L₹1 Cr₹2 Cr₹5 Cr₹3 Cr₹8 Cr₹5 Cr₹7 Cr₹6 Cr₹2 Cr₹3 Cr₹2 Cr₹1 Cr-₹1 Cr₹8 Cr₹5 Cr₹3 Cr₹12 Cr₹10 Cr₹6 Cr₹4 Cr₹7 Cr₹6 Cr₹6 Cr₹7 Cr₹5 Cr₹6 Cr₹9 Cr₹5 Cr
₹876 Cr₹759 Cr₹807 Cr₹795 Cr₹776 Cr₹713 Cr₹732 Cr₹746 Cr₹721 Cr₹566 Cr₹491 Cr₹509 Cr₹468 Cr₹404 Cr₹425 Cr₹466 Cr₹401 Cr₹314 Cr₹337 Cr₹367 Cr₹355 Cr₹280 Cr₹313 Cr₹332 Cr₹295 Cr₹248 Cr₹275 Cr₹290 Cr₹277 Cr₹227 Cr₹263 Cr₹270 Cr₹254 Cr₹219 Cr₹215 Cr₹256 Cr₹192 Cr₹189 Cr₹190 Cr₹208 Cr₹188 Cr
₹649 Cr₹553 Cr₹596 Cr₹573 Cr₹567 Cr₹530 Cr₹558 Cr₹557 Cr₹545 Cr₹456 Cr₹357 Cr₹366 Cr₹338 Cr₹319 Cr₹316 Cr₹338 Cr₹293 Cr₹227 Cr₹227 Cr₹235 Cr₹237 Cr₹195 Cr₹214 Cr₹216 Cr₹200 Cr₹186 Cr₹202 Cr₹187 Cr₹181 Cr₹164 Cr₹168 Cr₹172 Cr₹169 Cr₹150 Cr₹135 Cr₹157 Cr₹118 Cr₹141 Cr₹118 Cr₹130 Cr₹114 Cr
₹299 Cr₹276 Cr₹282 Cr₹291 Cr₹279 Cr₹260 Cr₹255 Cr₹269 Cr₹252 Cr₹164 Cr₹180 Cr₹185 Cr₹171 Cr₹120 Cr₹139 Cr₹157 Cr₹132 Cr₹105 Cr₹127 Cr₹147 Cr₹132 Cr₹97 Cr₹110 Cr₹127 Cr₹105 Cr₹76 Cr₹85 Cr₹115 Cr₹107 Cr₹74 Cr₹104 Cr₹107 Cr₹92 Cr₹79 Cr₹87 Cr₹104 Cr₹78 Cr₹54 Cr₹78 Cr₹83 Cr₹79 Cr
₹47 Cr₹46 Cr₹49 Cr₹50 Cr₹49 Cr₹54 Cr₹57 Cr₹59 Cr₹60 Cr₹33 Cr₹18 Cr₹16 Cr₹17 Cr₹9 Cr₹3 Cr₹7 Cr₹7 Cr₹1 Cr₹1 Cr₹1 Cr₹78 L₹54 L₹40 L₹45 L₹41 L₹35 L₹39 L₹51 L₹91 L₹4 Cr₹5 Cr₹6 Cr₹7 Cr₹8 Cr₹3 Cr₹2 L₹2 L₹19 L₹3 L₹79 L₹3 L
₹180 Cr₹161 Cr₹145 Cr₹172 Cr₹160 Cr₹129 Cr₹116 Cr₹129 Cr₹116 Cr₹77 Cr₹116 Cr₹126 Cr₹112 Cr₹76 Cr₹107 Cr₹121 Cr₹101 Cr₹85 Cr₹109 Cr₹131 Cr₹117 Cr₹85 Cr₹99 Cr₹116 Cr₹95 Cr₹61 Cr₹72 Cr₹103 Cr₹95 Cr₹58 Cr₹89 Cr₹92 Cr₹78 Cr₹62 Cr₹77 Cr₹99 Cr₹74 Cr₹48 Cr₹72 Cr₹78 Cr₹73 Cr
₹144 Cr₹280 Cr₹109 Cr₹134 Cr₹124 Cr₹102 Cr₹87 Cr₹96 Cr₹90 Cr₹80 Cr₹101 Cr₹122 Cr₹94 Cr₹61 Cr₹100 Cr₹119 Cr₹93 Cr₹80 Cr₹101 Cr₹118 Cr₹107 Cr₹68 Cr₹90 Cr₹108 Cr₹89 Cr₹56 Cr₹63 Cr₹93 Cr₹84 Cr₹54 Cr₹80 Cr₹86 Cr₹72 Cr₹56 Cr₹75 Cr₹93 Cr₹71 Cr₹47 Cr₹68 Cr₹69 Cr₹63 Cr

Share Price Live Stats

Open (₹)1,301.00
Volume (₹)9,801.00
High (₹)1,324.30
Upper Circuit1,564.20
Low (₹)1,301.00
Lower Circuit1,042.80
Prev Close1,303.50
52W High (₹)1,797.60
Price1,313.40
52W Low (₹)1,200.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)18069.20 Cr
Div. Yield (%)0.00
PE Ratio28.06
Debt to Equity0.59
Price to Book4.62
Book Value280.75
EPS (TTM)46.46
Face Value1.00
ROE (%)19.23

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
ERISNSE
LTP
1W Low
1W High
Market cap (₹)
1905.8-14.2 (-0.74%)
1902
1984.80
4,56,833Cr
9211.5-27.5 (-0.30%)
9087
9467
2,45,426Cr
4894-156 (-3.09%)
4885
5066
1,87,320Cr
1134-57 (-4.79%)
1125.10
1187
1,13,217Cr
1391.5-32 (-2.25%)
1376.70
1426.10
1,12,212Cr
1853.6-84.9 (-4.38%)
1811.70
1949
1,01,155Cr
2124.1-47.4 (-2.18%)
2118.10
2192
97,626Cr
2348-34.9 (-1.46%)
2341.20
2419.20
96,859Cr
1163.3-14.7 (-1.25%)
1154.40
1179.90
96,406Cr
1656.7+11.4 (0.69%)
1622.60
1717
93,614Cr
1313.4-1.4 (-0.11%)
1265.10
1349.90
18,069Cr

Key Highlights of Eris Lifesciences Ltd’s P&L

In 2025-03-31, Eris Lifesciences Ltd reported total revenue of ₹2912Cr, compared with ₹2032.97Cr in 2024-03-31, reflecting Eris Lifesciences Ltd turnover.

Depreciation was ₹315.46Cr and finance costs were ₹231.29Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹488.87Cr in 2025-03-31 as compared to ₹431.34Cr in 2024-03-31.

Net Profit (PAT) was ₹351.84Cr in 2025-03-31 compared with ₹392.05Cr in 2024-03-31.

Earnings per share (EPS) were ₹25.83 in 2025-03-31, compared with ₹28.83 in 2024-03-31.